Global Markets
Merck (MRK GY) to buy Silence Therapeutics for USD 20/ADS in cash
StockNow breaking-news AI analysis
The headline reports Merck’s proposed cash purchase of Silence Therapeutics at USD 20 per ADS; no article text is available to confirm further terms.
Related stocks
2 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
